GLP-1ClinicsNearMe

Weight Loss Clinics in Charleston, South Carolina

Looking for a weight loss clinic that prescribes GLP-1 medications? Our directory lists 87 verified providers serving Charleston, South Carolina (157,665 residents · 34.6% adult obesity).

Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.

Find Your Clinic ↓Browse Full Directory →

Top 10 GLP-1 Clinics in Charleston

4.8

Sweetgrass Plastic Surgery — Physician-supervised GLP-1 weight loss program serving Charleston and Summerville. 6% body weight loss in 3 months, 11% at 6 months. Personalized program. 4.9H

SemaglutideIn-Person
3.8

Klinic — Charleston Telehealth — Telehealth GLP-1 prescriptions serving Charleston-area patients. Board-certified weight loss specialists. 4.9H This directory is for informational purposes only. Not medical advice. Consult your healthcare provider. — TheGLP1Guide.net 14

OzempicTelehealthIn-Person

Pricing: $49+/mo

More GLP-1 Resources

Independent network of GLP-1 resources serving Charleston and patients across the U.S.

What to Look for in a GLP-1 Clinic

Choosing the right GLP-1 provider in Charleston matters. Look for clinics that offer:

GLP-1 Medications Explained

GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:

Cost & Insurance in South Carolina

SC Healthy Connections Medicaid covers GLP-1 for diabetes only.

For state regulation info, see the South Carolina Medical Board.

Frequently Asked Questions

How many GLP-1 clinics are in Charleston?

Our directory lists 87 verified GLP-1 clinics in the Charleston area, with rankings based on patient reviews, services offered, and verified provider status.

Does insurance cover GLP-1 medications in South Carolina?

SC Healthy Connections Medicaid covers GLP-1 for diabetes only.

Are compounded GLP-1 medications still available?

Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.